يعرض 1,301 - 1,320 نتائج من 28,883 نتيجة بحث عن '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1301
  2. 1302
  3. 1303
  4. 1304
  5. 1305
  6. 1306

    Gene clustering identifies up- and down-regulated groups that control development, pluripotency, and cell division. حسب Michael Shelton (382572)

    منشور في 2019
    "…<p>Pluripotent H9 hESCs were differentiated for 50 days as previously described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0222946#pone.0222946.ref012" target="_blank">12</a>], beginning with high (7.5 μM or 10 μM) CHIR99021 concentrations. mRNA samples from the indicated time points were subjected to gene expression profiling. …"
  7. 1307
  8. 1308
  9. 1309
  10. 1310

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study حسب Elora C. Brenneman (795723)

    منشور في 2015
    "…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …"
  11. 1311
  12. 1312
  13. 1313
  14. 1314
  15. 1315
  16. 1316
  17. 1317

    Data Sheet 1_Reduced hemolytic complement activity in the classical pathway (CH50) is a risk factor for poor clinical outcomes of patients with infections: a retrospective analysis... حسب Hiroyuki Koami (3878434)

    منشور في 2025
    "…</p>Results<p>Of 2,726 patients who met the inclusion criteria, logistic regression models demonstrated that decreased CH50 is a significant predictor of 180-day mortality (OR: 0.98-0.99). …"
  18. 1318
  19. 1319
  20. 1320

    A Minor (<50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China حسب Yinuo Tan (705777)

    منشور في 2015
    "…<div><p>Background</p><p>We performed a retrospective study to determine the cancer-specific survival of colorectal cancer patients with a component of signet-ring cells or mucin comprising < 50% of the tumor mass.…"